Aveo Oncology has a total of 365 patents globally, out of which 149 have been granted. Of these 365 patents, more than 38% patents are active. The USA is where Aveo Oncology has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, the USA seems to be the main focused R&D center of Aveo Oncology and is also the origin country of the firm.
Aveo Oncology was founded in the year 2001 by Kenneth E. Weg, Lynda Chin, Paul Hurley and Ronald A. DePinho. The company is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics. It has been acquired by LG Chem.
Do read about some of the most popular patents of Aveo Oncology which have been covered by us in this article and also you can find Aveo Oncology patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Aveo Oncology patent portfolio.
How many patents does Aveo Oncology have?
Aveo Oncology has a total of 365 patents globally. These patents belong to 70 unique patent families. Out of 365 patents, 141 patents are active.
How Many Patents did Aveo Oncology File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Aveo Oncology Applications Filed | Aveo Oncology Patents Granted |
| 2022 | 4 | 7 |
| 2021 | 8 | 17 |
| 2020 | 4 | 11 |
| 2019 | 9 | 8 |
| 2018 | 6 | 6 |
| 2017 | 11 | 7 |
| 2016 | 5 | 9 |
| 2015 | 32 | 11 |
| 2014 | 1 | 4 |
| 2013 | 37 | 11 |
| 2012 | 35 | 17 |
| 2011 | 46 | 25 |
How many Aveo Oncology patents are Alive/Dead?
Worldwide Patents
How Many Patents did Aveo Oncology File in Different Countries?
Countries in which Aveo Oncology Filed Patents
| Country | Patents |
| United States Of America | 64 |
| Europe | 35 |
| Japan | 28 |
| Australia | 25 |
| Canada | 17 |
| Austria | 12 |
| China | 12 |
| Korea (South) | 9 |
| Spain | 9 |
| Germany | 9 |
| Hong Kong (S.A.R.) | 9 |
| Brazil | 8 |
| Mexico | 8 |
| Israel | 7 |
| Singapore | 5 |
| Norway | 5 |
| Denmark | 5 |
| South Africa | 5 |
| New Zealand | 5 |
| India | 5 |
| Argentina | 5 |
| Philippines | 4 |
| Indonesia | 3 |
| Poland | 3 |
| Russia | 3 |
| Portugal | 2 |
| Italy | 2 |
| Hungary | 1 |
| Taiwan | 1 |
| Malta | 1 |
Where are Research Centres of Aveo Oncology Patents Located?
10 Best Aveo Oncology Patents
US8187601B2 is the most popular patent in the Aveo Oncology portfolio. It has received 40 citations so far from companies like Genentech and Affinia Therapeutics.
Below is the list of 10 most cited patents of Aveo Oncology:
| Publication Number | Citation Count |
| US8187601B2 | 40 |
| US7649083B2 | 30 |
| US20130165337A1 | 28 |
| WO2012149014A1 | 20 |
| WO2011005273A1 | 20 |
| US8481687B2 | 19 |
| WO2012003472A1 | 18 |
| US7659378B2 | 17 |
| WO2016049470A1 | 17 |
| WO2011156617A2 | 16 |
What are Aveo Oncology key innovation segments?
What Technologies are Covered by Aveo Oncology?
The chart below distributes patents filed by Aveo Oncology